Tolvaptan and Colchicine: Interaction Details
AI-assisted, pharmacist-reviewed · AI content regenerated Jul 11, 2026 · Source data updated Jul 2, 2026 · Sources: FDA labeling, DDInter 2.0, cited literature
Colchicine
Tolvaptan
How we grade severity & evidence
Severity levels
- Contraindicated: These should generally not be used together.
- Major: Potentially serious — often needs a change or close monitoring.
- Moderate: Can be significant — usually manageable with monitoring.
- Minor: Usually limited clinical impact.
Evidence grades
- Established: Well documented — supported by controlled studies or strong clinical data.
- Probable: Good supporting evidence, though not definitively proven.
- Suspected: Some evidence suggests this interaction, but it is not well established.
- Possible: Limited or conflicting evidence; the interaction may occur.
- Theoretical: Predicted from the drugs' pharmacology; not yet confirmed in people.
Ratings come from the documented interaction literature and are reviewed by a pharmacist. They describe the documented risk of the combination, not what will necessarily happen to you — your dose, timing, and health picture all matter.
Let's talk about taking colchicine (for gout or pericarditis) together with tolvaptan (Jynarque or Samsca). Your body normally uses a kind of "pump" called P-gp to clear colchicine out. Tolvaptan can slow that pump down, so colchicine can build up to higher levels than intended.
That matters because too much colchicine can cause serious problems like bad diarrhea, muscle weakness, and effects on blood cells. Because of this risk, these two are usually not used together. Please don't stop or change either medicine on your own. Instead, let your pharmacist or doctor know you take both, and they can sort out the safest plan for you.
Effect: Increased colchicine exposure and risk of colchicine toxicity.
Mechanism: Colchicine is a P-gp (and CYP3A4) substrate. Tolvaptan inhibits P-gp, reducing colchicine efflux and increasing systemic exposure. Neither drug is a prodrug, so the interaction increases colchicine effect/toxicity.
- Severity: Contraindicated per labeling.
- Evidence: Theoretical (extrapolated from P-gp inhibitor class data).
- Onset: Unspecified.
Management: Avoid combination, especially with renal or hepatic impairment (fatal toxicity reported). If unavoidable in normal organ function, reduce colchicine daily dose or dosing frequency and monitor closely for GI, myelosuppressive, and neuromuscular toxicity.
What happens
Increased colchicine exposure and an increased risk of colchicine toxicity
Interaction Deep Dive
Colchicine acts as a substrate for both CYP3A4 and P-gp. Reports of toxicity have emerged when colchicine was given alongside clarithromycin, which inhibits both CYP3A4 and P-gp. Similar toxicities have been documented when colchicine was combined with a CYP3A4 inhibitor and when it was combined with a P-gp inhibitor3. Taking colchicine together with P-gp inhibitors is contraindicated, since life-threatening and fatal colchicine toxicity has been observed in such patients even at therapeutic colchicine doses 1. This combination is likewise contraindicated in individuals with renal or hepatic impairment, because life-threatening and fatal drug interactions have been reported. For patients whose renal and hepatic function is normal 2, when colchicine must be given together with a P-gp inhibitor, modify the colchicine dose by lowering either the daily amount or the frequency of dosing. Watch closely for signs of colchicine toxicity 3.
Why it happens (mechanism)
Inhibition of P-gp-mediated colchicine efflux transport
How to manage this interaction
The main step here is a conversation with your care team, because this pairing is generally avoided.
- Keep taking both exactly as prescribed until you speak with your pharmacist or prescriber. Don't stop on your own.
- Tell your team you take both, and mention any kidney or liver problems, which make the combination especially risky.
- If both are truly needed, your colchicine dose may need to be adjusted and individualized (a lower daily dose or less frequent dosing), and your team may monitor you more closely.
- Report signs of colchicine toxicity right away: severe diarrhea, vomiting, muscle weakness or pain, numbness, or unusual bruising, fever, or infection.
Management is individual — confirm any change with your pharmacist or prescriber.
Common questions
Can I take Tolvaptan and Colchicine together?
Tolvaptan can raise colchicine levels toward toxic amounts, so this combination is generally avoided; check with your pharmacist or doctor before taking both, especially if you have kidney or liver issues. Always confirm with your pharmacist or prescriber before making any change.
How serious is the Tolvaptan and Colchicine interaction?
It is rated contraindicated. These should generally not be used together.
How quickly could this interaction happen?
The documented onset is "unspecified". The timing of this interaction is not well characterized.
How is the Tolvaptan and Colchicine interaction managed?
The main step here is a conversation with your care team, because this pairing is generally avoided. Keep taking both exactly as prescribed until you speak with your pharmacist or prescriber. Don't stop on your own. Tell your team you take both, and mention any kidney or liver problems, which make the combination especially risky. If both are truly needed, your colchicine dose may need to be adjus… Management is individual — always follow your own care team's guidance.
How strong is the evidence for this interaction?
The evidence is graded "theoretical". Predicted from the drugs' pharmacology; not yet confirmed in people.
Questions for your pharmacist
- Does my dose of Tolvaptan or Colchicine need adjusting while I take them together?
- What symptoms should prompt me to call you or my prescriber right away?
- Does the timing of my doses matter for this combination?
- Is there a safer alternative to one of these medications for me?
References (3)
- Product Information: LODOCO(R) oral tablets, colchicine oral tablets. AGEPHA Pharma USA, LLC (per FDA), Parsippany, NJ, 2023. DailyMed
- Product Information: COLCRYS oral tablets, colchicine oral tablets. Takeda Pharmaceuticals America Inc (per FDA), Deerfield, IL, 2020. DailyMed
- Product Information: GLOPERBA(R) oral solution, colchicine oral solution. Romeg Therapeutics LLC (per FDA), Woburn, MA, 2019. DailyMed
Keep reading about Colchicine
Keep reading about Tolvaptan
These medications also interact with supplements
Prescription drugs aren't the whole picture — herbal and dietary supplements can interact with them too. From the evidence-graded Natural Medicines database:
major · moderate · minor — check everything you take with our drug–supplement interaction checker.
Check another combination
Our instant two-drug interaction checker is almost here.
Still have questions about this combination?
Every question gets a real answer from a licensed pharmacist — free, and usually within a day.
Ask the pharmacist